Next 10 |
home / stock / mgnx / mgnx articles
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024 Initiation of Phase 1 study of ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing, manufact...
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose...
ROCKVILLE, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing, manufactur...
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. Steelcase posted upbeat earnings for its...
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday. Shares of The Toro Company (NYSE: TTC) rose sharply durin...
As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in th...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
News, Short Squeeze, Breakout and More Instantly...
2024-03-16 23:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-08 00:30:17 ET Image source: The Motley Fool. MacroGenics (NASDAQ: MGNX) Q4 2023 Earnings Call Mar 07, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024 Initiation of Phase 1 study of ...